Epidemiological Investigation of Iranian Patients with Pulmonary Embolism Based on Medication
| Author | Mohammad Kalateh Agha Mohammadi | en |
| Author | Haniyeh Ghaffari Nazari | en |
| Author | Sheida Yazdani | en |
| Author | Sharmin Fateh Babamiri | en |
| Author | Abbas Hajifathali | en |
| Author | Mahshid Mehdizadeh | en |
| Author | Katayoun Najafizadeh | en |
| Orcid | Abbas Hajifathali [0000-0002-2711-9277] | en |
| Orcid | Mahshid Mehdizadeh [0000-0002-8937-5495] | en |
| Orcid | Katayoun Najafizadeh [0000-0003-2453-1669] | en |
| Issued Date | 2025-01-31 | en |
| Abstract | Background: The primary cause of mortality in pulmonary embolism (PE) is believed to be the lack of emergency treatment. Objectives: This study aimed to assess the outcomes of primary treatment and evaluate complications based on the type of medication used in Iranian PE patients after hospital discharge. Methods: This retrospective study was conducted on 108 PE patients admitted to Shohada Tajrish Hospital, Tehran, Iran, during 2018 - 2019. Clinical manifestations, treatment methods, drug-related complications, and prognosis were analyzed within six months post-discharge. Results: A significant association was observed between underlying diseases and the mortality rate (P < 0.05). The frequency of prescribed medications in PE patients was as follows: 60% for rivaroxaban, 9% for apixaban, 14% for warfarin, and 17.5% for enoxaparin. No significant correlation was found between death, bleeding, and the type of drug used. Conclusions: The increased mortality rate in PE patients is strongly associated with underlying conditions, such as cancer. The use of anticoagulants significantly reduces mortality rates in PE patients. | en |
| DOI | https://doi.org/10.5812/zjrms-148879 | en |
| Keyword | Pulmonary Embolism | en |
| Keyword | Rivaroxaban | en |
| Keyword | Apixaban | en |
| Keyword | Warfarin | en |
| Keyword | Enoxaparin | en |
| Publisher | Brieflands | en |
| Title | Epidemiological Investigation of Iranian Patients with Pulmonary Embolism Based on Medication | en |
| Type | Brief Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- zjrms-27-1-148879-publish-pdf.pdf
- Size:
- 515.68 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF